AU2016903295A0 - Viral Vaccines - Google Patents
Viral VaccinesInfo
- Publication number
- AU2016903295A0 AU2016903295A0 AU2016903295A AU2016903295A AU2016903295A0 AU 2016903295 A0 AU2016903295 A0 AU 2016903295A0 AU 2016903295 A AU2016903295 A AU 2016903295A AU 2016903295 A AU2016903295 A AU 2016903295A AU 2016903295 A0 AU2016903295 A0 AU 2016903295A0
- Authority
- AU
- Australia
- Prior art keywords
- viral vaccines
- vaccines
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960004854 VIRAL VACCINES Drugs 0.000 title 1
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2019107582A RU2778312C2 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
ARP170102311A AR110624A1 (en) | 2016-08-19 | 2017-08-18 | VIRAL VACCINES |
CA3034282A CA3034282A1 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
EP23215911.1A EP4331676A3 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
CN201780063830.0A CN109862909A (en) | 2016-08-19 | 2017-08-18 | Viral vaccine |
PCT/AU2017/050879 WO2018032057A1 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
MX2019001919A MX2019001919A (en) | 2016-08-19 | 2017-08-18 | Viral vaccines. |
KR1020197007662A KR20190050787A (en) | 2016-08-19 | 2017-08-18 | Antivirus |
AU2017313450A AU2017313450B2 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
IL264893A IL264893B (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
US16/325,539 US10905759B2 (en) | 2016-08-19 | 2017-08-18 | Vector-based attenuated poxvirus vaccines |
TW106128111A TWI728173B (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
MA045994A MA45994A (en) | 2016-08-19 | 2017-08-18 | VACCINES AGAINST VIRUSES |
SG11201900814QA SG11201900814QA (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
EP17840633.6A EP3500280A4 (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
BR112019003181A BR112019003181A2 (en) | 2016-08-19 | 2017-08-18 | composition for enhancing an animal immune response, method for inducing a protective immune response in a subject, and use of the composition for preparing a medicament. |
NZ750578A NZ750578A (en) | 2016-08-19 | 2017-08-18 | Viral vaccines |
JP2019508842A JP2019528271A (en) | 2016-08-19 | 2017-08-18 | Virus vaccine |
CL2019000405A CL2019000405A1 (en) | 2016-08-19 | 2019-02-14 | Viral vaccines |
US17/130,165 US20210113684A1 (en) | 2016-08-19 | 2020-12-22 | Vector-based attenuated poxvirus vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2016903295A0 true AU2016903295A0 (en) | 2016-09-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3713601A4 (en) | Epstein-barr virus vaccines | |
EP3538146A4 (en) | Influenza vaccine | |
EP3364983A4 (en) | Respiratory virus vaccines | |
IL258833A (en) | Herpes simplex virus vaccine | |
HK1246183A1 (en) | Hpv vaccines | |
EP3324979A4 (en) | Infectious disease vaccines | |
EP3364949A4 (en) | Cancer vaccines | |
IL267949A (en) | Altered virus | |
EP3134131A4 (en) | Nucleic acid vaccines | |
EP3700565A4 (en) | Adjuvanted vaccines | |
EP3419660A4 (en) | Novel vaccines against zika virus | |
EP3273989A4 (en) | Streptococcal vaccine | |
EP3194595A4 (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
EP3200878A4 (en) | Hiv vaccines comprising one or more population episensus antigens | |
EP3113795A4 (en) | Recombinant isfahan viral vectors | |
EP3104883A4 (en) | Tilapia lake virus vaccines | |
EP3312431A4 (en) | Blower | |
EP3515929A4 (en) | Hepatitis b therapeutic vaccines | |
EP3528843A4 (en) | Anti-opioid vaccines | |
SG11202001244SA (en) | Hpv vaccine | |
EP3562498A4 (en) | Influenza vaccines | |
GB201616904D0 (en) | Vaccine | |
EP3277707A4 (en) | Antibodies against infectious diseases | |
EP3500280A4 (en) | Viral vaccines | |
GB201608821D0 (en) | Vaccines |